RhumbLine Advisers
ZURA icon

RhumbLine Advisers’s Zura Bio ZURA Stock Holding History

RhumbLine Advisers’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$389K Buy
+65,888
New +$314K ﹤0.01% 2915
2025
Q2 		– Sell
-36,577
Closed -$47.2K – 4277
2025
Q1 		$47.2K Sell
36,577
-1,080
-3% -$1.7K ﹤0.01% 3591
2024
Q4 		$94.1K Buy
37,657
+10,231
+37% +$36.4K ﹤0.01% 3492
2024
Q3 		$111K Buy
27,426
+10,532
+62% +$39.3K ﹤0.01% 3470
2024
Q2 		$59.1K Buy
16,894
+1,371
+9% +$5.59K ﹤0.01% 3641
2024
Q1 		$39.9K Buy
15,523
+556
+4% +$1.97K ﹤0.01% 3675
2023
Q4 		$69.9K Buy
14,967
+3,768
+34% +$18.8K ﹤0.01% 3553
2023
Q3 		$73.9K Buy
11,199
+3,089
+38% +$20.6K ﹤0.01% 3553
2023
Q2 		$66.5K Buy
+8,110
New +$65.2K ﹤0.01% 3623

Other funds holding ZURA

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

RhumbLine Advisers's ZURA Position: Q2 2026 in Review

RhumbLine Advisers opened a new position in Zura Bio (ZURA) in Q2 2026: 65,888 shares worth $389K. The stake represents ﹤0.01% of the portfolio and ranks #2915 among its holdings. This is a return to the name: RhumbLine Advisers previously reported a position in ZURA as recently as Q1 2025.

RhumbLine Advisers first reported a position in ZURA in Q2 2023 and has held it in 9 quarters since. 95 funds tracked by Wall St. Rank hold ZURA as of Q2 2026.

  • RhumbLine Advisers held 65,888 shares of Zura Bio worth $389K as of Q2 2026.
  • Zura Bio was a new RhumbLine Advisers position in Q2 2026.
  • Zura Bio made up ﹤0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #2915 holding.
  • RhumbLine Advisers first reported a position in Zura Bio in Q2 2023 and has held it in 9 quarters since.
  • 95 funds tracked by Wall St. Rank held Zura Bio as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.